The global market for mass spectrometry, already surpassing $3 billion, is expected to grow by eight percent per year through the end of the decade, according to Spectroscopy Magazine and Instrument Business Outlook. The growth is fueled by continual advancements in technology, which have positioned mass spectrometry
The following article identifies the benefits of bringing in outside maintenance expertise to perform functions that otherwise consume resources that can be better used in a production mode. Ron Hoffman With today's limited
In the fiercely competitive medical device and instrumentation industry, speeding time to market is important to edge out competitors and begin generating revenue for products that often carry long and expensive research and development cycles. Pushing products through the development
When the Wall Street Journal, New York Times, Business Week, and USA Today all have articles discussing the most recent entrant to the Personal Health Record (PHR) space, then something significant might be happening. Regardless of Google’s success in its
DNA has begun to be considered as a possibility for molecular electronics. At Israel’s Weizmann Institute of Science, scanning probe microscopy and negative stiffness vibration isolation enables nano level DNA research. by Jim McMahon Because DNA is able to recognize
Total cost of ownership in sync with Pre Growth strategies With the economic outlook today, it would appear that controllers and engineers are in direct opposition when searching for methods to enhance the bottom line. Controllers want to reduce expenditures
With commercial survival at the top of everyone’s agenda, many medical device and equipment manufacturers are looking to antimicrobial technology to give their product the edge, or to help them diversify into new markets. As BioCote’s sales manager Graham Harvey
The healthcare and life science industries are going through a change in methodology of treatment and cost containment pressures under a focused government controlled or nationally administered health insurance program. These new pressure points are making the pharmaceutical and medical device industry re-evaluate target therapy, point of administration, method of administration, portability of the product, country of origin, associated costs, and convenience for use.
Power sources for medical devices must accommodate numerous requirements, from duration to size to durability. The market offers a plethora of choices of both primary (non-rechargeable) and secondary (rechargeable) batteries in a great variety of shapes, sizes, and chemistries. This article focuses on design considerations for primary cells, with a brief look at secondary cells.
How Are You Influencing Orthopedic Technology? Dr. Greg Hetland President, International
How Are You Influencing Portable Medical Technology? Dr. Robin Sarah Tichy Technical Marketing Engineer, Micro Power Electronics Inc. Micro Power Electronics specializes in the design and manufacture of custom battery packs that power portable medical devices.
How Are You Influencing Portable Medical Technology? Clark Hummel Application Engineer Manager, Intelligent Motion Systems Inc.
“The molding process is most effective when the designer and the molding company work closely from the beginning of the design process all the way to first article. Many molding concerns can be addressed at the design phase. It takes
Metal is no longer the only material option when discussing orthopedic implants. A variety of polymers are being indicated for both long term and bioresorbable devices. Additives and active pharmaceutical ingredients are also being utilized with these materials. This article examines the opportunities realized when using polymers for orthopedic implants.
Having a reliable external injection molded components supplier on speed dial seems like a more common requirement for today’s medical device design engineer. However, prior to making that choice, there are a number of aspects to evaluate